Skip to content

Drug interactions

Ciprofloxacin + Ipratropium-salbutamol

Severity: Minor

Ciprofloxacin and Ipratropium-salbutamol: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ciprofloxacin can prolong the QT interval, and salbutamol may add to this effect, especially at high doses or with hypokalemia. The risk is generally low with standard inhaled use but is higher in patients with other QT risk factors.

What this interaction means in plain words

Ciprofloxacin and Ipratropium-salbutamol have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Ciprofloxacin belongs to Anti Bacterial; Ipratropium-salbutamol belongs to Respiratory.

Evidence level: Low

Why it happens

Additive QT prolongation, with possible salbutamol-induced hypokalemia.

What to do

No routine action is needed at usual doses. Check ECG and potassium in patients with other QT-prolonging drugs, electrolyte disturbance or heart disease.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ciprofloxacin and Ipratropium-salbutamol, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Ciprofloxacin with Ipratropium-salbutamol?

MediHelp rates the interaction as minor. Ciprofloxacin and Ipratropium-salbutamol have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Ciprofloxacin can prolong the QT interval, and salbutamol may add to this effect, especially at high doses or with hypokalemia. The risk is generally low with standard inhaled use but is higher in patients with other QT risk factors.

How serious is the interaction between Ciprofloxacin and Ipratropium-salbutamol?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine action is needed at usual doses. Check ECG and potassium in patients with other QT-prolonging drugs, electrolyte disturbance or heart disease.

What other medicines interact with Ipratropium-salbutamol?

MediHelp also lists interactions of Ipratropium-salbutamol with, for example, Amisulpride, Arsenic trioxide, Carvedilol. The full list is on the Ipratropium-salbutamol page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in